Occam Places Phil Tagari as CSO at insitro
insitro, a Casdin/ARCH/GV investment, is a data-driven drug discovery and development company using machine learning and computation at scale to transform the way that drugs are discovered and developed for patients. Since its founding in mid-2018, the San Francisco-based company has raised over $800M from top tech, biotech, and crossover investors.
Philip Tagari was placed as insitro’s CSO in late 2022. Tagari joined insitro following a 24-year career at Amgen, where he led the organization's research platforms for over a decade as Vice President, Research - Therapeutic Discovery.
View recent Placements
.avif)
.avif)
.avif)
.avif)
DISCOVER OCCAM GLOBAL
Occam Global is a leading executive search and advisory partner for entrepreneurs, investors, and corporations targeting exceptional goals across the life sciences, deep tech, and venture capital sectors worldwide. Since 2012, Occam has collaborated with top founders, CEOs, and investors across the tech industry to provide high-performing leaders who fuel growth. From stealth startups to public markets, we recruit senior executives, advise on organizational strategies, and invest alongside visionary teams to build innovative companies.
Occam’s success is rooted in our proven ability to attract outstanding business and scientific leaders, seamless access to rare talent, and a strong commitment to results guided by high ethics and enlightened aggression. Whether you’re launching, leading, or investing, we are here to support growth through the power of talent.